Collaboration bridges the gap between employer-provided
psychedelic therapy access and clinician training
NEW
YORK, June 26, 2024 /PRNewswire-PRWeb/ --
Fluence, a leading psychedelic therapy training company, and
Enthea, a third-party administrator (TPA) of health insurance
plans, and the only one offering psychedelic healthcare as a
workplace benefit, today announced a strategic partnership to
expand reimbursement for services from Fluence-trained clinicians
offering ketamine-assisted therapy.
By combining Enthea's commitment to
expanding access to psychedelic-assisted therapy with our expertise
in training mental health professionals, we can work together to
address the growing need for qualified practitioners in this
field.
Under the partnership, Fluence will offer clinicians who meet
Enthea's participation requirements a 20% discount on Psychedelic
Therapy Integration (PTI) and Ketamine-Assisted Psychotherapy (KAP)
Certificate programs. This discount has the potential to increase
to 30% if the number of annual referrals from Enthea exceeds 100
participants. Enthea will consider Fluence's Advanced Certificate
in Ketamine-Assisted Therapy as a top-tier training option for
becoming credentialed as a member of its provider network.
"This partnership with Enthea substantially increases access to
reimbursement for services from graduates of our training programs.
Patients will know that their provider, when credentialed by
Enthea, has been trained to the highest industry standard, and
Enthea's client employers can rest assured their employees are
getting high quality care," said Elizabeth
Nielson, PhD, Co-founder and Chief Visionary Officer of
Fluence. "By combining Enthea's commitment to expanding access to
psychedelic-assisted therapy with our expertise in training mental
health professionals, we can work together to address the growing
need for qualified practitioners in this field."
Founded in 2019, Fluence has educated over 7,000 clinicians in
psychedelic-assisted therapy. Fluence offers a comprehensive suite
of training programs, including the MDMA-Assisted Therapy Education
Program, the Certificate in Ketamine-Assisted Psychotherapy, and
the Certificate in Psilocybin-Assisted Therapy for Oregon-based practitioners.
Enthea, established in 2022, is working to expedite health
insurance coverage for psychedelic treatments by partnering with
employers to add ketamine-assisted therapy to their employee
benefit plans. The company currently covers 153,000 lives and has
seen interest from various industries, including construction,
finance, retail, and tech.
"Our mission is to remove the barriers that prevent people from
accessing highly effective mental health treatments," said
Sherry Rais, CEO of Enthea. "By
partnering with Fluence, we can help ensure that as more people
gain access to ketamine-assisted therapy through their employee
benefits, there will be a growing network of qualified
practitioners ready to provide safe and effective care."
The partnership between Fluence and Enthea comes at a critical
time, as interest in psychedelic-assisted therapy continues to
grow. With MDMA-assisted therapy under consideration for FDA
approval in 2024 and legal access to psilocybin services in
Oregon and Colorado, the demand for trained practitioners
is higher than ever.
Fluence and Enthea's collaboration also underscores the
importance of training and education in the rapidly evolving field
of psychedelic medicine. By working together to expand access to
high-quality training programs, the two companies are helping to
set the standard for safe and effective psychedelic-assisted
therapy.
About Fluence
Fluence is the global leader in providing comprehensive,
evidence-based training in psychedelic therapy and integration to
healthcare professionals. With a mission to equip clinicians with
the clinical skills and knowledge necessary for effective,
evidence-based psychedelic therapy and integration services,
Fluence offers ethical, dynamic, interactive training both online
and in-person. Since its inception, Fluence has educated over 7,000
practitioners, establishing itself as a frontrunner in psychedelic
therapy training for private enterprises and research
organizations.
About Enthea
Enthea is a licensed, third-party administrator of ancillary
health insurance benefits with a mission to provide access to safe,
affordable and effective psychedelic-assisted therapies – starting
with ketamine therapy. Through Enthea, companies can readily add
coverage for these new and innovative treatments for their
employees and families – using safe and effective Enthea standards
of care. Studies show that true mental health improvements lead to
greater productivity, increased retention, lower medical costs, and
a more engaged workforce. Enthea's services currently cover
ketamine-based treatments and will expand to include MDMA- and
psilocybin-assisted therapies when and where they are approved.
Media Contact
Brad Burge, Fluence, 1
6508636887, brad@integrationcommunications.com,
https://www.fluencetraining.com
View original content to download
multimedia:https://www.prweb.com/releases/fluence-and-enthea-partner-to-expand-reimbursement-and-training-in-ketamine-assisted-therapy-302179944.html
SOURCE Fluence